| |
| |
|
| Insider
Information: |
Atlas Venture Associates Ix, Llc |
| Relationship: |
10% Owner |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
9,886,776 |
|
|
Indirect Shares
|
3,729,788 |
|
|
| Direct
Value |
$116,126,454 |
|
|
|
Indirect Value
|
$91,230,614 |
|
|
| Total
Shares |
13,616,564 |
|
|
| Total
Value |
$207,357,068 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -28.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Intellia Therapeutics, Inc. |
NTLA |
10% Owner |
2017-07-11 |
3,579,788 |
2017-03-10 |
3,729,788 |
Premium* |
|
|
Cogent Biosciences, Inc. |
COGT |
10% Owner |
2018-04-03 |
3,361,535 |
2018-04-03 |
0 |
Premium* |
|
|
Surface Oncology, Inc. |
SURF |
10% Owner |
2020-12-17 |
2,945,453 |
2018-04-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SURF |
Surface Oncology, Inc. |
10% Owner |
– – • |
2020-12-17 |
4 |
S |
$18.10 |
$30,770,000 |
D/D |
(1,700,000) |
2,945,453 |
0 |
% |
|
| SURF |
Surface Oncology, Inc. |
10% Owner |
– – • |
2018-04-23 |
4 |
B |
$15.00 |
$1,500,000 |
D/D |
100,000 |
4,645,453 |
2.45 |
- |
|
| SURF |
Surface Oncology, Inc. |
10% Owner |
– – • |
2018-04-23 |
4 |
A |
$0.00 |
$0 |
D/D |
3,181,817 |
4,545,453 |
0 |
- |
|
| COGT |
Cogent Biosciences, Inc. |
10% Owner |
– – • |
2018-04-03 |
4 |
B |
$12.00 |
$1,128,624 |
D/D |
94,052 |
3,361,535 |
2.45 |
- |
|
| COGT |
Cogent Biosciences, Inc. |
10% Owner |
– – • |
2018-04-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,267,483 |
3,267,483 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
10% Owner |
– – • |
2017-07-11 |
4 |
S |
$16.07 |
$1,285,560 |
D/D |
(80,000) |
3,579,788 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
10% Owner |
– – • |
2017-07-10 |
4 |
S |
$16.17 |
$646,888 |
D/D |
(40,000) |
3,659,788 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
10% Owner |
– – • |
2017-07-07 |
4 |
S |
$16.77 |
$502,992 |
D/D |
(30,000) |
3,699,788 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
10% Owner |
– – • |
2017-03-10 |
4 |
S |
$14.06 |
$77,410 |
D/D |
(5,504) |
0 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
10% Owner |
– – • |
2017-03-09 |
4 |
S |
$13.85 |
$216,432 |
D/D |
(15,628) |
5,504 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
10% Owner |
– – • |
2017-03-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(700,000) |
3,729,788 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
10% Owner |
– – • |
2016-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
4,429,788 |
4,429,788 |
0 |
- |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
